Mr. Hamed Shahbazi reports

WELL HEALTH IMPROVES GUIDANCE BASED ON WELL CANADA ACHIEVING $100 MILLION IN ANNUALIZED ADJUSTED EBITDA RUN-RATE AHEAD OF SCHEDULE

Well Health Technologies Corp. has achieved its goal of $100-million in annualized adjusted EBITDA(earnings before interest, taxes, depreciation and amortization) run rate for its Well Canada segment, three calendar quarters ahead of the timeline it had previously guided to, and at materially better margins. This milestone reflects the combined strength of Well's organic growth and its disciplined acquisition strategy across the Canadian business. In conjunction with reaching this milestone, Well also announced the closing of two complementary, immediately accretive clinical platform acquisitions: a network of outpatient diagnostic imaging clinics in Ontario operating primarily under the Ontario Imaging Diagnostics brand (OID Group), and a majority controlling interest in JDMD Inc. (UnionMD), one of Quebec's largest multidisciplinary health care platforms.

• Well has reached its goal of $100-million in annualized adjusted EBITDA run-rate for Well Canada, three calendar quarters ahead of schedule, driven by strong organic growth across Well Clinics and WellStar together with two accretive acquisitions.
• Well had previously guided a $100-million annualized adjusted EBITDA run rate by Q1 2027 on approximately $800-million of revenue. The company has delivered it on approximately $700-million of revenue, implying an adjusted EBITDA margin of approximately 14 per cent -- roughly 180 basis points ahead of prior guidance.
• On June 1, 2026, Well closed two complementary, immediately accretive acquisitions in Ontario and Quebec, focused on diagnostic imaging and procedural care: 100 per cent of the OID Group and approximately 65 per cent controlling interest in UnionMD. The company paid approximately $115-million at closing for both acquisitions, expanding its Canadian Clinics network to approximately 270 clinics nationally. The total purchase price for these two transactions could amount to $160-million, inclusive of future earnouts and vendor takeback financing.
• The two acquisitions generated combined adjusted EBITDA of approximately $22-million in 2025, reflecting adjusted EBITDA margins of Well over 25 per cent, and bringing Well Canadian Clinics to Well over $80-million in annualized adjusted EBITDA run rate.
• On the strength of this performance and the contribution of the completed acquisitions, Well now expects to exceed the top end of its previously announced 2026 adjusted EBITDA guidance range of $175-million to $185-million. The company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.

These two acquisitions generated combined adjusted EBITDA of approximately $22-million in 2025 reflecting adjusted EBITDA margins of Well over 25 per cent. With these acquisitions, Well's Canadian Clinics network has expanded to approximately 270 clinics, with approximately 2,350 billable health care providers. Together, they are expected to bring Well Canadian Clinics to well over $80-million in annualized adjusted EBITDA run rate and Well Canada, which includes Canadian Clinics, WellStar and CYBERWell, to over $100-million in annualized adjusted EBITDA run rate. Both acquisitions were fully financed through the company's cash on hand and existing credit facilities.

Reaching and exceeding $100-million in annualized adjusted EBITDA run rate for Well Canada represents a key milestone for the company. Through a combination of strong organic growth and disciplined acquisitions, Well has firmly reached this goal three calendar quarters earlier than previously guided. The company had previously guided that it expected to reach $100-million in annualized adjusted EBITDA run rate for Well Canada by the first quarter of 2027 on associated revenue of approximately $800-million. Well has delivered this run rate on associated revenue of approximately $700-million, implying an adjusted EBITDA margin of approximately 14 per cent -- approximately 180 basis points ahead of the margin implied by the company's prior guidance.

On the strength of this performance and the contribution of these completed acquisitions, Well expects to exceed the top end of its previously announced 2026 adjusted EBITDA guidance range of $175-million to $185-million. The company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.

Hamed Shahbazi, chairman and chief executive officer of Well, commented: "Reaching $100-million in annualized adjusted EBITDA run rate for Well Canada three calendar quarters ahead of schedule, and at materially better margins than we had guided to, is a milestone we are very proud of. What makes it especially meaningful is how we got here. This is the result of total performance across our Canadian business -- strong organic growth at both Well Clinics and WellStar, complemented by disciplined, accretive acquisitions. Our model is working, and we are reaching our goals faster and more profitably than planned. We now turn much of our attention to integration and operational execution across the platform. We look forward to sharing more with our second quarter results."

In Ontario, Well has acquired the OID Group, a network of outpatient diagnostic imaging clinics operating primarily under the Ontario Imaging Diagnostics brand. In Quebec, Well has acquired a majority controlling interest in UnionMD, one of the province's largest and multidisciplinary health care platforms, a procedure-first business. Both acquisitions achieved adjusted EBITDA margins of Well over 25 per cent in 2025. The aggregate purchase price paid at closing of $115-million for these two transactions was fully financed through proceeds from the newly expanded and extended senior secured credit facility arranged with a syndicate of lenders led by Royal Bank of Canada, JPMorgan Chase Bank, N.A. and Toronto-Dominion Bank in January, 2026. The total purchase price for these two transactions could amount up to $160-million, inclusive of future earnouts and vendor takeback financing.

Dr. Michael Frankel, president of Canadian Clinics, commented: "Both of these acquisitions bring strong, well-established clinical teams into the Well network and reflect the depth of talent that exists across the Canadian health care landscape. We look forward to bringing these clinics into the Well ecosystem, leveraging our shared services infrastructure and technology platforms to enhance operational efficiency and the experience for both patients and providers."

Beyond their standalone contribution, both acquisitions are expected to benefit from Well's shared services infrastructure, technology platforms and proven clinic operating model. Well has identified a range of opportunities to enhance performance across the acquired platforms, including expanded capacity and other synergies across Well's national network. The company believes these initiatives, combined with the platforms' already strong margin profiles, will further support Well Canada's profitability over time. Well intends to provide additional detail on its integration and value-creation plans in connection with announcing its second quarter financial results.

About Well Health Technologies Corp.

Well Health Technologies is Canada's largest outpatient health care company and a leading provider of technology-enabled health care solutions. Well is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI (artificial intelligence) and every piece of health data is protected. Well owns and operates approximately 270 clinics in Canada, supporting more than five million annual patient visits. Through its subsidiary WellStar, Well provides electronic medical records, artificial-intelligence-powered clinical tools, patient engagement platforms and IT management services. Well provides cybersecurity services through its CyberWell subsidiary. Well is publicly traded on the TSX under the symbol WELL and on the OTC exchange under the symbol WHTCF.

We seek Safe Harbor.